Marked genetic differences between pTa and pT1 papillary bladder cancer detected by comparative genomic hybridization

被引:0
|
作者
Richter, J
Feng, J
Sartorius, G
Gorog, JP
Moch, H
Egenter, C
Gasser, TC
Mihatsch, MJ
Sauter, G
机构
[1] UNIV BASEL,INST PATHOL,CH-4003 BASEL,SWITZERLAND
[2] UNIV BASEL,UROL CLIN,CH-4003 BASEL,SWITZERLAND
来源
CYTOGENETICS AND CELL GENETICS | 1997年 / 77卷 / 1-2期
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:W99 / W99
页数:1
相关论文
共 50 条
  • [31] Progressive genetic aberrations detected by comparative genomic hybridization in squamous cell cervical cancer
    D G Allen
    D J White
    A-M Hutchins
    J P Scurry
    S N Tabrizi
    S M Garland
    J E Armes
    British Journal of Cancer, 2000, 83 : 1659 - 1663
  • [32] Validation of the recently proposed EORTC prognostic algorithm for PTA/PT1 bladder transitional cell cancer (TCC)
    Pillai, Rajiv
    Wang, Duolao
    Abel, Paul
    JOURNAL OF UROLOGY, 2007, 177 (04): : 524 - 524
  • [33] Comparative Analysis of Histopathology Assessment Criteria to Predict Progression in PT1 Bladder Cancer
    Leivo, Mariah Z.
    Sahoo, Debashis
    Mirsadraei, Leili
    Hansel, Donna
    LABORATORY INVESTIGATION, 2017, 97 : 237A - 237A
  • [34] Comparative Analysis of Histopathology Assessment Criteria to Predict Progression in PT1 Bladder Cancer
    Leivo, Mariah Z.
    Sahoo, Debashis
    Mirsadraei, Leili
    Hansel, Donna
    MODERN PATHOLOGY, 2017, 30 : 237A - 237A
  • [35] Genetic differences between HPV-16-containing and -lacking oropharyngeal squamous cell carcinomas detected by comparative genomic hybridization
    Klussmann, P.
    Claessen, S.
    Preuss, S.
    Lehnen, M.
    Weissenborn, S.
    Hopman, A.
    Speel, E. J.
    ORAL ONCOLOGY, 2007, : 203 - 203
  • [36] FGFR3 and p53 protein expressions in patients with pTa and pT1 urothelial bladder cancer
    Mhawrech-Fauceglia, P
    Cheney, RT
    Fischer, G
    Beek, A
    Herrmann, FR
    EJSO, 2006, 32 (02): : 231 - 237
  • [37] Is the proposed EORTC prognostic algorithm for pTa/pT1 bladder transitional cell cancer (TCC) valid in a routine clinical setting?
    Pillai, R.
    Wang, D.
    Abel, P.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 172 - 172
  • [38] Progressive increase of genetic alteration in urinary bladder cancer by combined allelotyping analysis and comparative genomic hybridization
    Chan, Michael W. Y.
    Hui, Angela Bik-Yu
    Yip, Sidney Kam-Hung
    Ng, Chi-Fai
    Lo, Kwok-Wai
    Tong, Joanna H. M.
    Chan, Anthony W. H.
    Cheung, Ho Y.
    Wong, Wai S.
    Chan, Peter S. F.
    Lai, Fernand M. M.
    To, Ka-Fai
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 34 (04) : 963 - 970
  • [39] GENETIC ABERRATIONS DETECTED BY COMPARATIVE GENOMIC HYBRIDIZATION PREDICT OUTCOME IN NODE-NEGATIVE BREAST-CANCER
    ISOLA, JJ
    KALLIONIEMI, OP
    CHU, LW
    FUQUA, SAW
    HILSENBECK, SG
    OSBORNE, CK
    WALDMAN, FM
    AMERICAN JOURNAL OF PATHOLOGY, 1995, 147 (04): : 905 - 911
  • [40] Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping
    Cher, ML
    Bova, GS
    Moore, DH
    Small, EJ
    Carroll, PR
    Pin, SS
    Epstein, JI
    Isaacs, WB
    Jensen, RH
    CANCER RESEARCH, 1996, 56 (13) : 3091 - 3102